San Diego biotech Cidara Therapeutics just raised an impressive $42 million Series B round – with plans to speed up development of its antifungal and immunotherapy drugs, and bring them to clinical trial later this year. The startup has two antifungal programs underway – called Biafungin and Topifungin. Biafungin is meant to be a once-weekly intravenous […]
Cubist Pharmaceuticals (NASDAQ:CBST) has agreed to purchase Exton, Pennsylvania-based Adolor (NASDAQ:ADLR) in a $190 million deal. Adolor markets Entereg (alvimopan), a U.S. Food and Drug Administration-approved therapy that accelerates the recovery time following partial large- or small-bowel resection surgery. The drug is an oral, peripherally acting mu-opioid receptor antagonist. In the year to June 30, […]
Employee assistance programs have become essential tools for organizations aiming to address mental health challenges, reduce burnout and foster healthier workplaces.